PurePEPSBPC-157
Ordered BPC-157 from PurePEPS? Mail in a sample (US only) and let us test it for free.
Test my supplyPurePEPS BPC-157 has a mixed evidence profile, with early severe fill misses (+126%, +123%) and purity misses at 98.902% and 99.23%. Recent results are cleaner, so the trajectory is improving but not yet consistent.
We investigated who actually operates PurePEPS — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including PurePEPS rows.
Cancel anytime
About PurePEPS test results from Finnrick
PurePEPS is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 2 peptides and 10 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible PurePEPS peptides in this dataset are BPC-157 (7 tests), TB-500 (3 tests) and Tirzepatide (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 10 recent tests.
Ordered BPC-157 from PurePEPS? Mail in a sample (US only) and let us test it for free.
Test my supply